Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hair
Marketing
NAD reaches split decision on Kenvue-Hims & Hers hair ad row
The NAD delivered a mixed verdict, telling Hims & Hers Health to change certain claims while dismissing other challenges brought by Kenvue.
Nick Paul Taylor
Aug 25, 2026 3:38am
Veradermics reports ph. 2 win in female pattern hair loss
Jul 15, 2026 11:27am
Veradermics locks in $256M IPO, shares spike
Feb 5, 2026 10:01am
Veradermics grows hair loss med hopes on $150M funding wave
Oct 16, 2025 7:30am
Hair today, gone tomorrow: Minoxidil drug sellers hit by MHRA
Oct 12, 2022 9:05am
